Cary Street Partners Financial LLC Invests $80,000 in STERIS plc (NYSE:STE)

Cary Street Partners Financial LLC purchased a new stake in shares of STERIS plc (NYSE:STE) during the 4th quarter, Holdings Channel reports. The fund purchased 390 shares of the medical equipment provider’s stock, valued at approximately $80,000.

A number of other institutional investors have also added to or reduced their stakes in STE. Avalon Trust Co acquired a new stake in STERIS in the fourth quarter valued at approximately $30,000. Human Investing LLC bought a new stake in STERIS during the 4th quarter worth $31,000. Anfield Capital Management LLC increased its holdings in STERIS by 100.0% in the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after purchasing an additional 91 shares in the last quarter. Manchester Capital Management LLC raised its position in STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after purchasing an additional 137 shares during the last quarter. Finally, Brown Brothers Harriman & Co. boosted its stake in shares of STERIS by 66.7% during the fourth quarter. Brown Brothers Harriman & Co. now owns 220 shares of the medical equipment provider’s stock valued at $45,000 after purchasing an additional 88 shares in the last quarter. 94.69% of the stock is currently owned by institutional investors and hedge funds.

STERIS Stock Up 0.3%

STERIS stock opened at $226.54 on Monday. The firm has a market cap of $22.26 billion, a price-to-earnings ratio of 48.10 and a beta of 0.96. STERIS plc has a 52-week low of $200.98 and a 52-week high of $248.24. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. The firm has a 50 day moving average price of $223.40 and a two-hundred day moving average price of $218.80.

STERIS Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 26th. Investors of record on Tuesday, June 10th will be issued a $0.57 dividend. The ex-dividend date is Tuesday, June 10th. This represents a $2.28 annualized dividend and a yield of 1.01%. STERIS’s payout ratio is 48.41%.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research note on Monday, April 7th. Stephens raised shares of STERIS to a “strong-buy” rating in a research note on Thursday, May 1st. Piper Sandler boosted their price objective on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $265.00 target price on shares of STERIS in a research report on Thursday, April 10th. One equities research analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $258.75.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.